ABSTRACT
The purpose of this chapter is to describe the elements of analytical method validation promulgated by the U.S. Food and Drug Administration (FDA) for drug development, and to explain the reasoning for each component. This chapter is intended for individuals who are unfamiliar with analytical method validation, or new to drug development. Readers who are interested in more detailed experimental or statistical treatises of specific aspects of method validation are referred to elsewhere.
